Detalles de la búsqueda
1.
Medicinal chemistry perspective of JAK inhibitors: synthesis, biological profile, selectivity, and structure activity relationship.
Mol Divers
; 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236444
2.
An updated literature on BRAF inhibitors (2018-2023).
Mol Divers
; 2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37470921
3.
Medicinal Chemistry Perspectives on Recent Advances in Src Kinase Inhibitors as a Potential Target for the Development of Anticancer Agents: Biological Profile, Selectivity, Structure-Activity Relationship.
Chem Biodivers
; 20(9): e202300515, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563848
4.
Explanatory review on pyrimidine/fused pyrimidine derivatives as anticancer agents targeting Src kinase.
J Biomol Struct Dyn
; 42(3): 1582-1614, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37144746
5.
An assessment of EGFR and HER2 inhibitors with structure activity relationship of fused pyrimidine derivatives for breast cancer: a brief review.
J Biomol Struct Dyn
; 42(3): 1564-1581, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-37158086
6.
Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship.
Eur J Med Chem
; 274: 116535, 2024 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38838546
7.
An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC).
J Biomol Struct Dyn
; : 1-17, 2023 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37642992
Resultados
1 -
7
de 7
1
Próxima >
>>